Using @fytffee cash flow numbers and the websites detailed above I get:
The Discount rate has a large bearing on the Value, $70 at 6% discount is optimistic here (there is still risk in drug problems/ failure). Also there is a risk in the terminal years (beyond 10 years) at this value as it is 75% of the actual value, issues again may be drug problem/failure. Going beyond 10 years given patents may also be under debate.
Thanks for the cashflow projections to use in this calc.
Using @fytffee cash flow numbers and the websites detailed above...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.24 |
Change
-1.870(8.09%) |
Mkt cap ! $2.852B | |||
| Open | High | Low | Value | Volume |
| $22.50 | $22.70 | $21.21 | $8.164M | 370.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 91 | $21.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.25 | 25 | 2 |
View Market Depth
| Last trade - 12.44pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.90 |
Change
-1.870 ( 10.1 %) |
||||
| Open | High | Low | Volume | ||
| $22.45 | $22.67 | $20.82 | 222188 | ||
| Last updated 13.03pm 29/05/2024 ? | |||||
| NEU (ASX) Chart |